We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.


New Trading Tool: Live US Options Flow! Try it out.

RENX Renalytix Plc

2.50 (3.03%)
22 Sep 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Share Name Share Symbol Market Type Share ISIN Share Description
Renalytix Plc LSE:RENX London Ordinary Share GB00BYWL4Y04 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 3.03% 85.00 80.00 90.00 85.00 82.50 82.50 32,308 08:18:44
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Services, Nec 3.0 -56.7 -75.9 - 80.61

Renalytix PLC Notice of GM and Posting of Circular (0238Z)

11/05/2023 7:00am

UK Regulatory (RNS & others)

Renalytix (LSE:RENX)
Historical Stock Chart

From Mar 2023 to Sep 2023

Click Here for more Renalytix Charts.


RNS Number : 0238Z

Renalytix PLC

11 May 2023

Renalytix plc

("Renalytix" or the "Company")

Notice of General Meeting and Posting of Circular

LONDON and SALT LAKE CITY, May 11, 2023 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that a circular containing a notice convening a General Meeting to be held at the offices of Harwood Capital LLP, 6 Stratton Street Mayfair, London W1J 8LD at 3 p.m. (BST) on 8 June 2023, has today been posted to the Company's shareholders.

An electronic copy of the circular will shortly be available on the Company's website at www.renalytix.com in accordance with AIM Rule 20.

For further information, please contact:

Renalytix plc                                                                               www.renalytix.com 
James McCullough, CEO                                                                         Via Walbrook PR 
Stifel (Nominated Adviser, Joint Broker)                                                   Tel: 020 7710 7600 
Alex Price / Nicholas Moore / Nick Harland / Samira Essebiyea 
Investec Bank plc (Joint Broker)                                                           Tel: 020 7597 4000 
Gary Clarence / Shalin Bhamra 
Walbrook PR Limited                                            Tel: 020 7933 8780 or renalytix@walbrookpr.com 
Paul McManus / Lianne Applegarth                                           Mob: 07980 541 893 / 07584 391 303 
CapComm Partners 
Peter DeNardo                                                    Tel: 415-389-6400 or investors@renalytix.com 

About Renalytix

Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosis(TM) for kidney health. The leadership team, with a combined 200+ years of healthcare and in-vitro diagnostic experience, has designed its KidneyIntelX laboratory developed test to enable risk assessment for rapid progressive decline in kidney function in adult patients with T2D and early CKD (stages 1-3). We believe that by understanding how disease will progress, patients and providers can take action early to improve outcomes and reduce overall health system costs. For more information, visit www.renalytix.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

May 11, 2023 02:00 ET (06:00 GMT)

1 Year Renalytix Chart

1 Year Renalytix Chart

1 Month Renalytix Chart

1 Month Renalytix Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: gb D: 20230923 16:01:04